Dyne Therapeutics (DYN) Earnings Date & Reports

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

Industry: #Electric Utilities

Get AI intraday signals

A.I. Advisor

published Earnings

DYN is expected to report earnings to rise 2.74% to -75 cents per share on July 30

Dyne Therapeutics DYN Stock Earnings Reports

Q2'26

Est.

$-0.75

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.08

Q2'25

Missed

by $0.03

The last earnings report on May 11 showed earnings per share of -73 cents, beating the estimate of -76 cents. With 665.03K shares outstanding, the current market capitalization sits at 3.45B.

View a ticker or compare two or three

Compare

DYN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for DYN